Skip to search formSkip to main contentSkip to account menu

MM-121

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Purpose: Although there are many well-defined signaling pathways in tumor cells that provide druggable targets, emergence of… 
2015
2015
Purpose: Heregulin-mediated activation of the human epidermal growth factor receptor 3 (HER3/ErbB3) is required for the growth… 
2014
2014
The EGFR monoclonal antibody cetuximab is the only approved targeted agent for treating head and neck squamous cell carcinoma… 
2013
2013
MM-121/SAR 256212 is a fully human anti ErbB3/HER3 antibody that blocks ligand-induced receptor activation. Formation of EGFR… 
2012
2012
ErbB3 is a critical activator of phosphoinositide 3-kinase (PI3K) signaling in EGFR-, HER2-, and MET-addicted cancers, and ligand… 
2010
2010
In women, breast cancer is among the most common cancers and the fifth most common cause of cancer deaths. Due to the… 
2008
2008
3974 The role of the EGFR family in cancer is well documented. To date most of the attention has been focused on EGFR and ErbB2…